Tariffs and governmental uncertainty have been at the forefront of investors' minds. But while they may be factors, they may also be covering up for
A buy-the-dip approach is bolstering the chip maker as individual investors position for its shares to rally.
“Congestion pricing” is the stuffy-sounding name of a New York policy that is, by every available metric, a resounding success. Anyone, including lapsed
Dell Technologies is expected to report fiscal 2025 fourth-quarter results after markets close Thursday, with analysts calling for revenue growth driven
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the air freight and logistics industry, including FedEx
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how household
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year
(Bloomberg) -- There’s growing “suspicion” among investors about the scope for more S&P 500 gains at a time when European and Chinese stocks are
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to
Beverage company Keurig Dr Pepper (NASDAQ:KDP) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 5.2% year on year to
